Corticosteroids combined with continuous veno-venous hemodiafiltration for treatment of hantavirus pulmonary syndrome caused by Puumala virus infection

  • E. Seitsonen
  • M. Hynninen
  • E. Kolho
  • H. Kallio-Kokko
  • V. Pettilä
Concise Article

Abstract

Reported here are two cases of hantavirus pulmonary syndrome caused by Puumala virus infection, which rapidly resolved after initiation of corticosteroid treatment combined with continuous veno-venous hemodiafiltration. These cases emphasize the role of the inflammatory response in the pathogenesis of hantavirus pulmonary syndrome.

References

  1. 1.
    Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A (2003) Hantavirus infections in Europe. Review. Lancet Infect Dis 3:653–661CrossRefPubMedGoogle Scholar
  2. 2.
    Clement JP (2003) Hantavirus. Antiviral Res 57:121–127CrossRefPubMedGoogle Scholar
  3. 3.
    Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A (1996) Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol 46:369–378PubMedGoogle Scholar
  4. 4.
    Clement J, Colson P, McKenna P (1994) Hantavirus pulmonary syndrome in New England and Europe. N Engl J Med 331:545–546CrossRefPubMedGoogle Scholar
  5. 5.
    Launay D, Thomas C, Fleury D, Roueff S, Line M, Droz D, Vanhille P (2003) Pulmonary-renal syndrome due to hemorrhagic fever with renal syndrome: an unusual manifestation of Puumala virus infection in France. Clin Nephrol 59:297–300PubMedGoogle Scholar
  6. 6.
    Schütt M, Meisel H, Kruger D, Ulrich R, Dalhoff K, Dodt C (2004) Life-threatening Dobrava hantavirus infection with unusually extended pulmonary involvement. Clin Nephrol 62:54–57PubMedGoogle Scholar
  7. 7.
    Klempa B, Meisel H, Rath S, Bartel J, Ulrich R, Kruger D (2003) Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. J Clin Microbiol 41:4894–4897CrossRefPubMedGoogle Scholar
  8. 8.
    Vapalahti O, Lundkvist Å, Kallio-Kokko H, Paukku K, Julkunen I, Lankinen H, Vaheri A (1996) Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol 34:119–125PubMedGoogle Scholar
  9. 9.
    Kallio-Kokko H, Vapalahti O, Lundkvist Å, Vaheri A (1998) Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus-expressed nucleocapsid protein for early nephropathia epidemica diagnosis. Clin Diagn Virol 10:83–90CrossRefPubMedGoogle Scholar
  10. 10.
    Vapalahti O, Kallio-Kokko H, Närvänen A, Julkunen I, Lundkvist Å, Plyusnin A, Lehväslaiho H, Brummer-Korvenkontio M, Vaheri A, Lankinen H (1995) Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early response. J Med Virol 46:293–303PubMedCrossRefGoogle Scholar
  11. 11.
    Kallio-Kokko H, Leevelahti R, Brummer-Korvenkontio M, Lundkvist A, Vaheri A, Vapalahti O (2001) Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells. J Med Virol 65:605–613PubMedCrossRefGoogle Scholar
  12. 12.
    Kim E, Lee K, Primack S, Yoon H, Byun H, Kim T, Suh G, Kwon O, Han J (2002) Viral pneumonias in adults: radiologic and pathologic findings. RadioGraphics 22(Special issue):137–149Google Scholar
  13. 13.
    Peters C, Simpson G, Levy H (1999) Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 50:531–545CrossRefPubMedGoogle Scholar
  14. 14.
    Duchin J, Koster F, Peters C, Simpson G, Tempest B, Zaki S, Ksiazek T, Rollin P, Nichol S, Umland E et al (1994) Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med 330:949–955PubMedCrossRefGoogle Scholar
  15. 15.
    Hallin G, Simpson S, Crowell R, James D, Koster F, Mertz G, Levy H (1996) Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 24:252–258CrossRefPubMedGoogle Scholar
  16. 16.
    Ketai L, Williamson M, Telepak R, Levy H, Koster F, Nolte K, Allen S (1994) Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiology 191:665–668PubMedGoogle Scholar
  17. 17.
    Mori M, Rothman A, Kurane I, Montoya J, Nolte K, Norman J, Waite D, Koster F, Ennis F (1999) High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 179:295–302CrossRefPubMedGoogle Scholar
  18. 18.
    Terajima M, Hendershot J III, Kariwa H, Koster F, Hjelle B, Goade D, DeFronzo M, Ennis F (1999) High levels of viremia in patients with the Hantavirus pulmonary syndrome. J Infect Dis 180:2030–2034CrossRefPubMedGoogle Scholar
  19. 19.
    Artigas A, Bernard G, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini J, Matthay M, Pinsky M, Spragg R, Suter P, Consensus Committee (1998) The American–European consensus conference on ARDS, Part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med 24:378–398CrossRefPubMedGoogle Scholar
  20. 20.
    Groeneveld A (2002) Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vasc Pharmacol 39:247–256CrossRefGoogle Scholar
  21. 21.
    Riad M, Mogos M, Thangathurai D, Lumb P (2002) Steroids. Curr Opin Crit Care 8:281–284CrossRefPubMedGoogle Scholar
  22. 22.
    Metz C, Sibbald W (1991) Anti-inflammatory therapy for acute lung injury. A review of animal and clinical studies. Chest 100:1110–1119PubMedCrossRefGoogle Scholar
  23. 23.
    Chiang C, Wu C, Perng W, Yan H, Yu C (2000) Dexamethasone and pentastarch produce additive attenuation of ischaemia/reperfusion lung injury. Clin Sci 99:413–419CrossRefPubMedGoogle Scholar
  24. 24.
    Bone R, Fisher C Jr, Clemmer T, Slotman G, Metz C (1987) Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 92:1032–1036PubMedCrossRefGoogle Scholar
  25. 25.
    Meduri G, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062–1073PubMedCrossRefGoogle Scholar
  26. 26.
    Meduri G, Headley S, Golden E, Carson S, Umberger R, Kelso T, Tolley E (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. A randomized controlled trial. JAMA 280:159–165PubMedCrossRefGoogle Scholar
  27. 27.
    Castillo C, Naranjo J, Sepulveda A, Ossa G, Levy H (2001) Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 120:548–554CrossRefPubMedGoogle Scholar
  28. 28.
    Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H (1996) Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 78:47–55CrossRefPubMedGoogle Scholar
  29. 29.
    Clarkson M, Giblin L, O’Connel F, O’Kelly P, Walshe J, Conlon P, O’Meara Y, Dormon A, Campbell E, Donohoe J (2004) Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19:2778–2783CrossRefPubMedGoogle Scholar
  30. 30.
    Mustonen J, Partanen J, Kanerva M, Pietilä K, Vapalahti O, Pasternack A, Vaheri A (1996) Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 49:217–221PubMedCrossRefGoogle Scholar
  31. 31.
    Kanerva M, Vaheri A, Mustonen J, Partanen J (1998) High-producer allele of tumour necrosis factor-alpha is part of the susceptibility MHC haplotype in severe Puumala virus-induced nephropathia epidemica. Scand J Infect Dis 30:532–534CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • E. Seitsonen
    • 1
  • M. Hynninen
    • 2
  • E. Kolho
    • 3
  • H. Kallio-Kokko
    • 4
  • V. Pettilä
    • 2
  1. 1.Department of Anesthesiology and Intensive Care MedicineHelsinki University Central HospitalHelsinkiFinland
  2. 2.Department of Anesthesiology and Intensive Care MedicineHelsinki University Central HospitalHelsinkiFinland
  3. 3.Clinical Microbiology and Infectious DiseasesHelsinki University Central HospitalHelsinkiFinland
  4. 4.Department of Virology, Division of Clinical MicrobiologyHUSLAB -Helsinki University Central Hospital LaboratoryHelsinkiFinland

Personalised recommendations